Can someone explain in layman's what the S&S data
Post# of 30028
Posted On: 07/31/2014 6:16:48 PM
Can someone explain in layman's what the S&S data means?
Per Gerald's last blog: The Company made 3 poster presentations, the first at international conferences for the Company, on our proprietary LymPro Test® blood diagnostic for Alzheimer’s disease. We presented data that corroborated earlier findings on the relevance of cell cycle deficiencies in peripheral blood lymphocytes, and publicly outlined the conditions of Version 2 of the assay that we believe will be a major leap forward for LymPro. At the conference, the top-line data presented showed an accuracy of 78% in this Version 2, and many current shareholders have asked exactly how we can feel so good about that data as compared to previously published Work. To answer this question, there are a number of things that much first be put into context to inform the underlying understanding of how blood tests are developed, the statistical modeling employed to arrive at accuracy numbers, and most critically, the relevance of correlation of each individual marker within a panel to an ultimate diagnosis. - See more at: http://www.thechairmansblog.com/amarantus-bio...WQ8qg.dpuf
So no improvements in Version 2 ?
Per Gerald's last blog: The Company made 3 poster presentations, the first at international conferences for the Company, on our proprietary LymPro Test® blood diagnostic for Alzheimer’s disease. We presented data that corroborated earlier findings on the relevance of cell cycle deficiencies in peripheral blood lymphocytes, and publicly outlined the conditions of Version 2 of the assay that we believe will be a major leap forward for LymPro. At the conference, the top-line data presented showed an accuracy of 78% in this Version 2, and many current shareholders have asked exactly how we can feel so good about that data as compared to previously published Work. To answer this question, there are a number of things that much first be put into context to inform the underlying understanding of how blood tests are developed, the statistical modeling employed to arrive at accuracy numbers, and most critically, the relevance of correlation of each individual marker within a panel to an ultimate diagnosis. - See more at: http://www.thechairmansblog.com/amarantus-bio...WQ8qg.dpuf
So no improvements in Version 2 ?
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼